# Comparison of 0.375% Ropivacaine and 0.25% Levobupivacaine for Infraclavicular Brachial Plexus Block

> **NCT03679897** · PHASE4 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 46 (actual)

## Conditions studied

- Regional Anesthesia

## Interventions

- **DRUG:** Ropivacaine solution
- **DRUG:** Levobupivacaine solution

## Key facts

- **NCT ID:** NCT03679897
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-18
- **Primary completion:** 2018-12-07
- **Final completion:** 2018-12-08
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2018-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03679897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03679897, "Comparison of 0.375% Ropivacaine and 0.25% Levobupivacaine for Infraclavicular Brachial Plexus Block". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03679897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*